Pharmigene--™s Genetic Test for Carbamazepine Response Now Standard in 50 Taiwan Hospitals | Pharmacogenomics Reporter | DxPGx | GenomeWeb
Links shared publicly online about this topic.
- 367total visits
Pharmigene--™s Genetic Test for Carbamazepine Response Now Standard in 50 Taiwan Hospitals | Pharmacogenomics Reporter | DxPGx | GenomeWeb
View full resource at genomeweb.com
Tags: Genetic, Seizure Medication, Bipolar Disorder Medication, Neuropathic Pain Medication, Lab Test, Hospital, Tegretol, Epilepsy Medication
Most Recently Shared on April 13, 2011 at 7:42 pm By:
Pharmigene’s Genetic Test for Carbamazepine Response Now Standard in 50 Taiwan Hospitals: Pharmigene said last w... http://bit.ly/esmkr3
University of Washington, Pharmigene Announce Licensing Agreement for Personalized Medicine Technology | IVD Technology
ivdtechnology.com — “The University of Washington Center for Commercialization (UW C4C) and Pharmigene announced the execution of a licensing agreement between the parties. The agreement settles a U.S. patent interference concerning previously competing applications that describe methods to determine proper dosing of the popular anti-coagulant drug, warfarin. Pharmigene is now the global licensee of VKORC1-1639 SNP related patents and application from both the University of Washington and Academia Sinica, Taiwan.” View full resource at ivdtechnology.com
Most Recently Shared on May 17, 2011 at 6:21 pm By:
IVD Technology Health Magazine
University of Washington, Pharmigene Announce Licensing Agreement for Personalized Medicine Technology http://tinyurl.com/4y5yjlj
Pharmacogenomics Becomes Standard In Over 50 Hospitals Throughout Taiwan Through Use Of New Genetic Screening Kit
medicalnewstoday.com — “Pharmigene, a leader in advancing personalized medicine and reducing severe adverse drug reactions through genetic-based diagnostic solutions, announced a new milestone in the practice of pharmaco” View full resource at medicalnewstoday.com
Most Recently Shared on March 14, 2011 at 6:15 am By:
Pharmacogenomics Becomes Standard In Over 50 Hospitals Throughout Taiwan Through Use Of New Genetic Screening Ki... http://bit.ly/eanmyJ
Pharmacogenomics Becomes Standard In Over 50 Hospitals Throughout Taiwan Through Use Of New Genetic Screening Kit
medicalnewstoday.com — “Pharmigene, a leader in advancing personalized medicine and reducing severe adverse drug reactions through genetic-based diagnostic solutions, announced a new milestone in the practice of pharmaco” View full resource at medicalnewstoday.com
Most Recently Shared on March 13, 2011 at 8:05 am By:
Pharmacogenomics Becomes Standard In Over 50 Hospitals Throughout Taiwan Through Use Of New Genetic Screening Kit http://mnt.to/3Sbz
Pharmigene Partners with Hospitals in Taiwan on Companion IVDs | IVD Technology
ivdtechnology.com — “Pharmigene announced a new milestone in the practice of pharmacogenomics and personalized medicine by partnering with over 50 hospitals across Taiwan. Healthcare providers at these institutions in Taiwan are utilizing Pharmigene--™s genetic test used to detect the presence of a key human leukocyte antigen (HLA) allele, HLA-B*1502, in individual patients being considered for treatment with the drug carbamazepine.” View full resource at ivdtechnology.com
Most Recently Shared on March 10, 2011 at 6:36 pm By:
IVD Technology Health Magazine
Pharmigene Partners with Hospitals in Taiwan on Companion IVDs http://tinyurl.com/4restv7
Advertisement
